(Q82862202)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16544121%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

[Effect of subtype and psychiatric comorbidities on methylphenidate treatment in adults with attention-deficit hyperactivity disorder] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16544121%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

E Sobanski

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16544121%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

B Alm

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16544121%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

B Krumm

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16544121%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

1 March 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16544121%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16544121%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

78

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16544121%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16544121%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

328-30, 333-37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16544121%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00115-006-2068-0

18 January 2020

exact match

0 references

cites work

Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status.

1 reference

12 December 2020

Venlafaxine versus stimulant therapy in patients with dual diagnosis ADD and depression

1 reference

12 December 2020

Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment

1 reference

12 December 2020

[Reliability and validity of the Wender-Utah-Rating-Scale short form. Retrospective assessment of symptoms for attention deficit/hyperactivity disorder]

1 reference

12 December 2020

Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: a case series.

1 reference

12 December 2020

Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial.

1 reference

12 December 2020

Young adults with attention deficit hyperactivity disorder: subtype differences in comorbidity, educational, and clinical history.

1 reference

12 December 2020

Co-existing disorders in ADHD -- implications for diagnosis and intervention

1 reference

12 December 2020

The US National Comorbidity Survey Replication (NCS-R): design and field procedures.

1 reference

12 December 2020

ADHD in adulthood--guidelines based on expert consensus with DGPPN support

1 reference

12 December 2020

A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults

1 reference

12 December 2020

A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder.

1 reference

12 December 2020

A randomized, double-blind, crossover study of methylphenidate and lithium in adults with attention-deficit/hyperactivity disorder: preliminary findings

1 reference

12 December 2020

Methylphenidate effects on symptoms of attention deficit disorder in adults.

1 reference

12 December 2020

Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder

1 reference

12 December 2020